These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38457255)

  • 21. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
    Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
    BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response.
    Su Y; Zhang T; Lu J; Qian L; Fei Y; Zhang L; Fan S; Zhou J; Tang J; Chen H; Liang C
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
    Qiu X; Gu Y; Ni Y; Li Q
    Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
    Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
    J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
    Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
    Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma.
    Deng Q; Du Y; Wang Z; Chen Y; Wang J; Liang H; Zhang D
    BMC Genomics; 2023 Jun; 24(1):307. PubMed ID: 37286941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
    Huang S; Hou Y; Hu M; Hu J; Liu X
    BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
    Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
    Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
    Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
    Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of EYA1/3/4 in clear cell renal cell carcinoma: a study from multiple databases.
    Liu T; Nie J; Zhang X; Deng X; Fu B
    Sci Rep; 2023 May; 13(1):7442. PubMed ID: 37156847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.